Ligand validation:3CLB

TMQ: TRIMETREXATE

TMQ is a Ligand Of Interest in 3CLB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CLB_TMQ_C_613	47%	30%	0.178	0.917	1.35	1.46	2	6	1	0	100%	1
3CLB_TMQ_A_611	35%	29%	0.212	0.902	1.33	1.5	2	6	4	0	100%	1
3CLB_TMQ_D_614	32%	33%	0.203	0.878	1.3	1.35	2	2	0	0	100%	1
3CLB_TMQ_B_612	1%	31%	0.483	0.586	1.29	1.45	2	5	3	0	100%	0.5
3HBB_TMQ_C_613	53%	18%	0.163	0.923	1.47	2.02	4	7	2	0	100%	1
2X9V_TMQ_B_1270	97%	44%	0.06	0.974	0.84	1.33	1	5	0	0	100%	1
4XT8_TMQ_A_302	64%	34%	0.139	0.939	0.88	1.72	1	9	2	0	100%	1
4M2X_TMQ_C_202	52%	1%	0.17	0.929	5.54	2.1	19	10	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.